The findings of this meta-analysis suggest DAPT with ticagrelor and aspirin has a higher probability of being the superior treatment among patients with minor stroke when presence of CYP2C19 loss-of-function alleles has not been excluded. This evidence concerns the gene CYP2C19 and stroke disorder.